Karin Walker
Direktor/Vorstandsmitglied bei CYCLACEL PHARMACEUTICALS, INC.
Profil
Karin L.
Walker is an Independent Non-Executive Director at Cyclacel Pharmaceuticals, Inc. since 2020.
She is also the Chief Accounting Officer at Prothena Corp.
Plc since 2013.
Previously, she served as an Independent Director at LifeSci Acquisition Corp.
in 2020.
From 2006 to 2009, she was the Vice President-Finance & Controller at CV Therapeutics, Inc. She then held the same position at Amyris, Inc. from 2009 to 2012.
In 2012, she became the Chief Accounting Officer & Vice President-Finance at Affymax, Inc. Before her corporate roles, she worked as an Accountant at Ernst & Young US LLP.
Ms. Walker obtained her undergraduate degree from California Polytechnic State University (San Luis Obispo).
Aktive Positionen von Karin Walker
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTHENA CORPORATION PLC | Comptroller/Controller/Auditor | 20.05.2013 |
| CYCLACEL PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 09.11.2020 |
Ehemalige bekannte Positionen von Karin Walker
| Unternehmen | Position | Ende |
|---|---|---|
| VINCERX PHARMA, INC. | Direktor/Vorstandsmitglied | 23.12.2020 |
| AFFYMAX, INC. | Comptroller/Controller/Auditor | 01.05.2013 |
| AMYRIS, INC. | Comptroller/Controller/Auditor | 01.01.2012 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Comptroller/Controller/Auditor | 01.01.2009 |
Ernst & Young US LLP
 Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young US LLP was engaged in providing accounting services. The company was headquartered in Pittsburgh, PA. | Corporate Officer/Principal | - |
Ausbildung von Karin Walker
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| AFFYMAX, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| AMYRIS, INC. | Process Industries |
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance LifeSci Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on December 19, 2018 and is headquartered in New York, NY. | Finance |
Ernst & Young US LLP
Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young US LLP was engaged in providing accounting services. The company was headquartered in Pittsburgh, PA. | Commercial Services |
